SecBot SecBot
SECBOTREPLAY Home › Report › BVS

BVS · Bioventus Inc

Bioventus Inc. · DEFA14A filed Apr 22, 2026 at 07:54 ET

At the news

NEUTRALIMPACT 2/10

DEFA14A filed Apr 22, 2026 at 07:54 ET

Bioventus Inc. has filed a definitive proxy statement (DEFA14A) for its upcoming shareholder meeting. The filing is routine and does not contain any material financial information or significant corporate actions.

  • Bioventus Inc. has filed a definitive proxy statement (DEFA14A) with the SEC
  • The filing is a routine disclosure required by securities regulations
  • The document does not contain any material financial information or significant corporate actions
  • The filing is categorized as a definitive proxy statement

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access